Posted in | News | Water

Xylem to Use UV AOP Technology in Municipal Drinking Water System in South Korea

Xylem Inc, a leading global water technology company focused on addressing the world’s most challenging water issues, today announced that it has won a significant contract to treat municipal drinking water for a new high-tech industrial zone in South Korea. The contract will involve using ultraviolet (UV) advanced oxidation process (AOP) technology for the first time in a municipal drinking water system in the country.

The water treatment facility will treat more than 26 million gallons per day, and will be the first step in the development of the new $3 billion Sihwa Multi-Tech Valley project, a government-backed regional industrial development initiative being implemented by the K-Water municipality. The new hub for the enterprise is due to be completed by 2016, and aims to attract high-tech industries across the IT, chemicals and R&D sectors.

“This award demonstrates Xylem’s dedication to innovation, advanced technology and our focus on helping our customers solve global water challenges by investing in the right solutions,” said Gretchen McClain, president and CEO of Xylem.

“This is a very prestigious contract to win and a very exciting initiative. We look forward to working with K-Water and bringing the benefits of our extensive experience and advanced water treatment solutions to this project in Korea,” said Kwang-Yeul Chung, managing director of Xylem in Korea.

Xylem’s WEDECO® UV K-reactors and WEDECO Advanced Oxidation Process technology will be used in the existing plant, Siheung wastewater treatment plant, which will become the first UV AOP application for a municipal drinking water system in South Korea. Xylem’s solution incorporates oxidation and UV disinfection to remove micro-pollutants, resulting in high-quality drinking water.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.